Teiko.bio maps immune profiles to guide immunotherapy and personalized medicine by analyzing interactions between immune and tumor cells to produce actionable data for biopharma clients. Its core offering, the customizable TokuProfile panel with 35+ immune markers, generates an immune fingerprint for each patient to identify predictive markers and monitor treatment impact. The company earns revenue from selling panels and data-analysis services, providing end-to-end immune profiling tailored to drug development and patient stratification. Its goal is to help biopharma companies develop more effective therapies and improve patient outcomes through precise immune data.
Company Size
11-50
Company Stage
N/A
Total Funding
N/A
Headquarters
Salt Lake City, Utah
Founded
2020
See people who can refer or advise you
Help us improve and share your feedback! Did you find this helpful?